News from chromadex corp A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-BB:CDXC)

Jun 19, 2014, 08:25 ET

ChromaDex Signs Collaboration Research Agreement with St. Jude Children's Research Hospital

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based...

May 28, 2014, 08:25 ET

ChromaDex and JQMS Announce Exclusive Sales and Marketing Agreement for GMP Compliance Services

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

May 13, 2014, 08:25 ET

ChromaDex Initiates Second Human Clinical Study for its Caffeine Ingredient, PURENERGY®

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

May 05, 2014, 08:25 ET

ChromaDex Signs Material Transfer Agreement With Wageningen University for NIAGEN™ Research

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Apr 23, 2014, 16:53 ET

UM Technology Management Division and Research Partners Land National Award

 A collaboration formed by the University of Mississippi's Division of Technology Management, the USDA Agricultural Research Service's Natural...

Apr 23, 2014, 08:25 ET

ChromaDex Provides Update on $62 Million Ingredient Agreement with Network Marketing Company 5LINX®

 ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and...

Apr 16, 2014, 08:25 ET

ChromaDex CEO, Frank Jaksch, to Speak at 13th Annual Oxford International Conference on the Science of Botanicals

 ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Apr 15, 2014, 08:25 ET

ChromaDex Signs Material Transfer Agreement With University of Copenhagen for NIAGEN™ Nicotinamide Riboside Research

 ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Apr 02, 2014, 08:30 ET

Thorne Research Introduces a New Product, NiaCel™, Featuring NIAGEN™, To Support Healthy Aging

 Thorne Research today announced the launch of NiaCel™, an innovative nutritional supplement that supports endurance, energy, and...

Mar 27, 2014, 06:45 ET

ChromaDex® Reports 2013 Full-Year Results

ChromaDex® Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to...

Mar 12, 2014, 08:25 ET

ChromaDex Signs Material Transfer Agreement With Leading Dutch University for NIAGEN™ Research

 ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Mar 06, 2014, 08:20 ET

ChromaDex to Present at the 26th Annual ROTH Conference on March 10th at 4:30 pm PDT

 ChromaDex Corp.® (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions...

Nov 05, 2013, 08:20 ET

Universite Libre de Bruxelles and ChromaDex® To Collaborate on NIAGEN™ Nicotinamide Riboside Research

 ChromaDex Corp.® (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients...

Oct 30, 2013, 08:20 ET

ChromaDex® Receives ISO/IEC 17025:2005 Certification

ChromaDex Corp.® (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to...

Oct 21, 2013, 06:30 ET

ChromaDex Receives Strategic Investment From DSM Venturing

 ChromaDex Corp.® (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients...

Jul 08, 2013, 08:25 ET

ChromaDex® Announces Deal For Its Recently Launched Niagen™ Nicotinamide Riboside With Thorne Research

 ChromaDex Corp.® (OTCBB: CDXC) ("ChromaDex" or the "Company"), an innovative natural products company that provides proprietary,...

Apr 02, 2012, 06:30 ET
ChromaDex Corporation Logo.  (PRNewsFoto/ChromaDex Corporation)

ChromaDex® and Platinum Performance® Collaborate on Development of Platinum Longevity™, an Equine Supplement Featuring the Novel Ingredient pTeroGold™

 ChromaDex Corp. (OTCBB: CDXC), an innovative natural products company and marketer of patented pTeroPure®, today announced that they...

Sep 08, 2011, 08:30 ET
ChromaDex Corporation Logo.  (PRNewsFoto/ChromaDex Corporation)

ChromaDex®'s Novel Ingredient pTeroPure® to be Studied as Potential Treatment for Fighting Skin Cancers

ChromaDex® Corp. (OTCBB: CDXC) today announced that the University of California, Irvine has granted ChromaDex® the exclusive rights to...

Aug 22, 2011, 06:00 ET

ChromaDex® Announces Partnership with Leading Creative Agency Alcone and Public Relations Leader Chandler Chicco Agency

ChromaDex® Corp. (OTCBB: CDXC), Alcone, an Omnicom Group Inc. company, and Chandler Chicco Agency, an inVentiv Health company, today announced...

Jul 13, 2011, 08:40 ET

ChromaDex Licenses Nicotinamide Riboside Technology from Cornell University

ChromaDex Corp. (OTCBB.:CDXC) today announced that Cornell University has granted the natural products company ChromaDex exclusive worldwide rights...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
ReportBuyer
Investor-Edge